Respiratory Infections and Anti-Infective Medication Use From Phase 3 Dupilumab Respiratory Studies
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Respiratory Infections and Anti-Infective Medication Use From Phase 3 Dupilumab Respiratory Studies
Authors
Keywords
-
Journal
Journal of Allergy and Clinical Immunology-In Practice
Volume -, Issue -, Pages -
Publisher
Elsevier BV
Online
2021-12-22
DOI
10.1016/j.jaip.2021.12.006
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- RV‐C infections result in greater clinical symptoms and epithelial responses compared to RV‐A infections in patients with CRS
- (2020) Amanda L. Willis et al. ALLERGY
- Disseminated Coccidioidomycosis Treated with Interferon-γ and Dupilumab
- (2020) Monica Tsai et al. NEW ENGLAND JOURNAL OF MEDICINE
- Chronic Rhinosinusitis With Nasal Polyps and Asthma
- (2020) Tanya M. Laidlaw et al. Journal of Allergy and Clinical Immunology-In Practice
- Infections in Dupilumab Clinical Trials in Atopic Dermatitis: A Comprehensive Pooled Analysis
- (2019) Lawrence F. Eichenfield et al. AMERICAN JOURNAL OF CLINICAL DERMATOLOGY
- Cross-talk between TH2 and TH17 pathways in patients with chronic rhinosinusitis with nasal polyps
- (2019) Min Wang et al. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY
- Epidemiology of Asthma in Children and Adults
- (2019) Shyamali C. Dharmage et al. Frontiers in Pediatrics
- Efficacy and safety of dupilumab in patients with severe chronic rhinosinusitis with nasal polyps (LIBERTY NP SINUS-24 and LIBERTY NP SINUS-52): results from two multicentre, randomised, double-blind, placebo-controlled, parallel-group phase 3 trials
- (2019) Claus Bachert et al. LANCET
- Dual blockade of IL‐4 and IL‐13 with dupilumab, an IL‐4Rα antibody, is required to broadly inhibit type 2 inflammation
- (2019) Audrey Le Floc’h et al. ALLERGY
- Risk of infection in patients with atopic dermatitis treated with dupilumab: A meta-analysis of randomized controlled trials
- (2018) Patrick Fleming et al. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY
- Efficacy and Safety of Dupilumab in Glucocorticoid-Dependent Severe Asthma
- (2018) Klaus F. Rabe et al. NEW ENGLAND JOURNAL OF MEDICINE
- Dupilumab Efficacy and Safety in Moderate-to-Severe Uncontrolled Asthma
- (2018) Mario Castro et al. NEW ENGLAND JOURNAL OF MEDICINE
- Commonality of the IL-4/IL-13 pathway in atopic diseases
- (2017) Namita A. Gandhi et al. Expert Review of Clinical Immunology
- Long-term management of moderate-to-severe atopic dermatitis with dupilumab and concomitant topical corticosteroids (LIBERTY AD CHRONOS): a 1-year, randomised, double-blinded, placebo-controlled, phase 3 trial
- (2017) Andrew Blauvelt et al. LANCET
- Dupilumab efficacy and safety in adults with uncontrolled persistent asthma despite use of medium-to-high-dose inhaled corticosteroids plus a long-acting β2 agonist: a randomised double-blind placebo-controlled pivotal phase 2b dose-ranging trial
- (2016) Sally Wenzel et al. LANCET
- Efficacy and safety of dupilumab in adults with moderate-to-severe atopic dermatitis inadequately controlled by topical treatments: a randomised, placebo-controlled, dose-ranging phase 2b trial
- (2016) Diamant Thaçi et al. LANCET
- Two Phase 3 Trials of Dupilumab versus Placebo in Atopic Dermatitis
- (2016) Eric L. Simpson et al. NEW ENGLAND JOURNAL OF MEDICINE
- Th2 cytokines impair innate immune responses to rhinovirus in respiratory epithelial cells
- (2015) M. Contoli et al. ALLERGY
- T H 2 and T H 17 inflammatory pathways are reciprocally regulated in asthma
- (2015) David F. Choy et al. Science Translational Medicine
- IL-33–Dependent Type 2 Inflammation during Rhinovirus-induced Asthma ExacerbationsIn Vivo
- (2014) David J. Jackson et al. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE
- Precise and in situ genetic humanization of 6 Mb of mouse immunoglobulin genes
- (2014) L. E. Macdonald et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Mice with megabase humanization of their immunoglobulin genes generate antibodies as efficiently as normal mice
- (2014) A. J. Murphy et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Defective epithelial barrier in chronic rhinosinusitis: The regulation of tight junctions by IFN-γ and IL-4
- (2012) Michael B. Soyka et al. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY
- Role of viral respiratory infections in asthma and asthma exacerbations
- (2010) William W Busse et al. LANCET
- Atopic Dermatitis
- (2008) Thomas Bieber NEW ENGLAND JOURNAL OF MEDICINE
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started